Figure 1 (Ica00 0002 01)
Icatibant Injection, Solution
Product Images NDC 63323-574
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 63323-574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Ica00 0002 02)
This text appears to be a statistical report indicating the percentage of patients who did not achieve a 50% reduction in symptoms. The value reported is 2% and there is also a reference to the time from dose measured in hours. It is unclear what specific medication or condition this report is referring to.*
Fresenius Kabi Logo (Ica00 0002 03)
Figure A (Ica00 0002 04)
This appears to be a product description for a pre-filled syringe that comes with a capped needle and an alcohol wipe. However, the text is incomplete and contains errors that make it difficult to decipher. The mention of a "protective cap" and "needle capseal" suggest that the syringe is designed for single-use and comes with safety features to prevent accidental needlestick injuries. The product may be intended for medical use or for self-administration of medication. The last line ("T-5 Toll o") is not interpretable and may be a result of errors.*
Figure B (Ica00 0002 05)
Figure C (Ica00 0002 06)
Figure D (Ica00 0002 07)
Figure E (Ica00 0002 08)
Figure F (Ica00 0002 09)
Figure G (Ica00 0002 10)
Figure H (Ica00 0002 11)
Figure I (Ica00 0002 12)
Figure J (Ica00 0002 13)
Figure K (Ica00 0002 14)
Figure L (Ica00 0002 15)
Figure M (Ica00 0002 16)
Figure N (Ica00 0002 17)
Figure O (Ica00 0002 18)
Fresenius Kabi Logo (Ica00 0002 19)
Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Syringe Label)
Icatibant injection is a medication available in a 30 mg per 3 mL dose for subcutaneous use only. It is manufactured by Fresenius Kabi in Austria and is prescription only. The LOT and EXP of the medication are not provided in the output.*
Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)
Icatibant Injection is a prescription medication available in a single-dose, pre-filled syringe with a hypodermic needle. It should only be administered subcutaneously and stored at temperatures between 22-26°C. The injection is free of preservatives and contains inactive ingredients such as ochiom chloride, glacial acetic acid, sodium hydroxide, and water for injection. The packaging also advises not to use if the seal on the syringe is broken.*
Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Syringe Label)
Icatibant injection is a medication that is administered subcutaneously and contains 30 mg of icatibant in 3 mL (10 mg/mL) concentration. This medication is manufactured by Fresenius Kabi in Austria and has a unique identification code of 3 63323-574-01 7. The lot number and expiration date are not available. It is important to note that this medication should only be used under supervision and with a valid prescription.*
Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)
Icatibant injection is a subcutaneous medication that comes in a prefilled syringe. It is preservative-free and contains sodium chloride, acetic acid, sodium hydroxide, and water for injection. The syringe is capped and delivered with a 255-podemon needle. The usual dosage should be seen in the package insert with patient injection instructions. The medication should be stored at 210-25°C and not frozen until administration. The container closure is not made with natural latex.*
Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
